p53 Activation Paradoxically Causes Liver Cancer

Michelle C. Barton, Guillermina Lozano

Research output: Contribution to journalArticlepeer-review

Abstract

Activation of p53 regulates a transcriptional program that can cause cell cycle arrest, senescence, apoptosis, and ferroptosis, which are potent tumor suppressive mechanisms. Unexpectedly, Makino and colleagues show in this issue of Cancer Research that the constitutive activation of p53 in murine hepatocytes leads to tumor development. Detailed analyses indicate that p53 activation leads to loss of hepatocytes, increased expression of chemokines and humoral factors, and expansion of the hepatic progenitor cell population. These progenitor cells are highly proliferative, show chromosomal instability, and eventually transform. In chronic liver disease in humans, activation of p53 is associated with increased liver cancer development. This study highlights the complexity and non-cell autonomous nature of the physiologic p53 response.

Original languageEnglish (US)
Pages (from-to)2824-2825
Number of pages2
JournalCancer Research
Volume82
Issue number16
DOIs
StatePublished - Aug 15 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'p53 Activation Paradoxically Causes Liver Cancer'. Together they form a unique fingerprint.

Cite this